COMMUNIQUÉS West-GlobeNewswire

Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
16/01/2025
Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarter Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that the National Institute [...]
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
14/01/2025
CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ [...]
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
14/01/2025
Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring revenue expected to be [...]
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
14/01/2025
FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance [...]
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
14/01/2025
Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Revenue of $68.2 to $68.7 Million Highest Quarterly MACI Implants [...]
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/01/2025
BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified [...]
Evaxion announces completion of ADS ratio change
14/01/2025
COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that [...]
OP Solutions Appoints Michael Kallish as Chief Executive Officer
14/01/2025
Experienced HIT Executive to Lead Next Stage of Growth for Orthotic & Prosthetic EMR Provider Tampa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- OP Solutions , the emerging leader in comprehensive technology solutions for [...]
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
14/01/2025
U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccines SAN FRANCISCO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
14/01/2025
Déclaration de transactions sur actions propres Paris, France (14 janvier 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 7 janvier 2025 [...]
Report on Carbios’ liquidity contract with Natixis ODDO BHF
14/01/2025
Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 14 January 2025 (6:00 pm CET). CARBIOS , (Euronext Growth Paris: ALCRB), a pioneer in the [...]
CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF
14/01/2025
Titre concerné : CARBIOS (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 14 janvier 2025 (18h00 CET). CARBIOS, (Euronext Growth Paris : ALCRB), pionnière dans le [...]
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
14/01/2025
Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024
14/01/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Vivid Health Joins Kno2 Network to Revolutionize Post-Acute Care
14/01/2025
Enhanced connectivity will bolster Vivid Health’s AI-assisted platform BOISE, Idaho, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Kno2, the company leading the future of healthcare communication, announced today a partnership with [...]
Conceivable Life Sciences Closes $18 Million Series A Financing to Advance Development and Commercialization of the World’s First AI-Powered Automated IVF Lab
14/01/2025
ARTIS Ventures led the financing with participation from new and existing investors, raising over $39 million to date Funds will support ongoing commercial pilot program in Mexico City and preparations for U.S. launch [...]
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025
14/01/2025
MINNEAPOLIS, MN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals today announced it will [...]
Centralis Health Delivers Connectivity Among Rural Hospitals in the Tallahassee Region
14/01/2025
George E. Weems Memorial Hospital’s addition to Centralis Health’s network ensures access to critical health information for rural patients and providers in northern Florida TALLAHASSEE, Fla., Jan. 14, 2025 (GLOBE [...]
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
14/01/2025
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical [...]

Pages